SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently trending as shareholders react to the official approval of a 1-for-12 reverse stock split, sparking intense debate over whether this move is a necessary structural correction or a sign of deeper financial distress. While some investors are expressing frustration over stagnant performance and leadership concerns, others are actively tracking heavy call option activity and speculating that the reduced float could set the stage for a potential short squeeze.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as traders debate its potential as a low-cap meme coin while community members highlight extreme volatility, aggressive pump-and-dump warnings, and widespread skepticism regarding its long-term viability.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing a surge in trading volume and investor interest following unconfirmed market rumors regarding potential M&A activity. Community members are actively debating the credibility of these reports while comparing the stock's current valuation and pipeline potential to past biotech acquisition trends.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is currently seeing intense investor scrutiny and volatility as the community remains deeply divided over the company's financial stability, impending trial readouts, and the performance of current leadership. Investors are actively debating the potential for a Phase 3 SENTRY trial success versus the significant risks posed by high debt levels and the necessity for strategic financing to extend operations.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan is trending as supporters position the token as the foundational "source code" or index of internet meme culture, emphasizing its high-supply tokenomics and 13-zero price point as a generational wealth opportunity. The community is actively discussing the token as a decentralized alternative to mainstream meme coins, citing its organic growth and long-term potential compared to projects heavily dependent on centralized exchange listings.

Hesai Group engages in the development, manufacture and sale of three-dimensional light detection and ranging(lidar) solutions. The company’s lidar products enable a broad spectrum of applications across passenger and commercial vehicles with advanced driver assistance systems (ADAS) and autonomous vehicle fleets. The company was founded by Yi Fan Li, Kai Sun, and Shao Qing Xiang in October 2014 and is headquartered in Shanghai, China.

Hesai Group - ADR

Hesai Group is trending following strong guidance for lidar shipments and revenue, alongside a strategic partnership with NVIDIA's AI inspection lab that strengthens its positioning in the autonomous and robotics sectors. While some investors are bullish on the company's market-leading growth and design wins with major OEMs, others are actively debating potential risks related to geopolitical tensions, audit transparency, and competitive threats in the lidar space.

Paycom Software, Inc. engages in the provision of cloud-based human capital management software solutions delivered as software-as-a-service. It offers functionality and data analytics that businesses need to manage the complete employment life cycle from recruitment to retirement. The company was founded by Chad R. Richison in 1998 and is headquartered in Oklahoma City, OK.

Paycom Software Inc

Paycom Software (PAYC) is facing heightened volatility and intense community debate as investors react to a challenging leadership landscape, ongoing insider selling, and significant growth deceleration. While some traders are attempting to bottom-fish the stock based on its strong balance sheet and automation potential, many others are expressing deep frustration over the company's corporate culture and disappointing performance guidance.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Estee Lauder is facing intense investor scrutiny following reports of potential merger talks with Puig, triggering high volatility and heavy volume as traders debate the long-term impact of potential dilution. The community remains sharply divided, with some betting on a strategic consolidation for a global beauty powerhouse while others fear the stock is caught in a wider sector rotation and tariff-related instability.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is currently seeing significant community buzz driven by expectations surrounding potential institutional-grade partnerships and an upcoming infrastructure roll-out that connects the project to wider payment ecosystems. While some investors are expressing skepticism about recent price action, many are actively accumulating tokens, citing the project's utility and the long-term potential of the network's ongoing integration efforts.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is currently a focal point for investors as the CEO prepares to testify before a House subcommittee regarding deep-sea mining, with momentum further fueled by the recent U.S.-Japan cooperative agreement on mineral supply chains. The community is actively debating the company's regulatory path and permit timeline, weighing the potential long-term strategic value of domestic critical mineral production against persistent skepticism from short sellers and market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera (BFRI) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Are Medical Stocks Lagging  Align Technology (ALGN) This Year?

Here is how Align Technology (ALGN) and Biofrontera Inc. (BFRI) have performed compared to their sector so far this year.

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Biofrontera Inc. (BFRI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year?

Here is how Biofrontera Inc. (BFRI) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Biofrontera Earnings Preview

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -3.70% and -75.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of +58.54% and +50.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +116.81% and +20.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.12	--	--	N/A
Q4 '25	$0.19	--	--	N/A
Q3 '25	-$0.58	-$0.62	-6.90%	MISSED
Q2 '25	-$0.42	-$0.57	-35.71%	MISSED
Q1 '25	-$0.22	-$0.47	-118.60%	MISSED

BFRI
Biofrontera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest BFRI News

BFRIBiofrontera Inc